Details for New Drug Application (NDA): 088262
✉ Email this page to a colleague
NDA 088262 describes IMIPRAMINE HYDROCHLORIDE, which is a drug marketed by Novartis, Chartwell, Leading, Lederle, Oxford Pharms, Par Pharm, Roxane, Sandoz, Specgx Llc, Strides Pharma, Sun Pharm Industries, Teva, Usl Pharma, Vangard, Watson Labs, and West Ward, and is included in thirty-six NDAs. It is available from twelve suppliers. Additional details are available on the IMIPRAMINE HYDROCHLORIDE profile page.
The generic ingredient in IMIPRAMINE HYDROCHLORIDE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.
The generic ingredient in IMIPRAMINE HYDROCHLORIDE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.
Summary for 088262
| Tradename: | IMIPRAMINE HYDROCHLORIDE |
| Applicant: | Strides Pharma |
| Ingredient: | imipramine hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 088262
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 088262 | ANDA | Strides Pharma Science Limited | 64380-170 | 64380-170-01 | 100 TABLET in 1 BOTTLE, PLASTIC (64380-170-01) |
| IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 088262 | ANDA | Strides Pharma Science Limited | 64380-170 | 64380-170-02 | 1000 TABLET in 1 BOTTLE, PLASTIC (64380-170-02) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Oct 21, 1983 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
